期刊
CELL METABOLISM
卷 27, 期 6, 页码 1294-+出版社
CELL PRESS
DOI: 10.1016/j.cmet.2018.04.013
关键词
-
资金
- Juvenile Diabetes Research Foundation International (JDRF)
- Max Planck Society
- ERC [ERC-StG-281641, ERC-CoG-682679]
- BMBF (DEEP) [EpiTriO 01KU1501A]
- MINECO [BFU2015_70581]
- AGAUR [2015FI_B_00632]
- EU_FP7
To date, it remains largely unclear to what extent chromatin machinery contributes to the susceptibility and progression of complex diseases. Here, we combine deep epigenome mapping with single-cell transcriptomics to mine for evidence of chromatin dysregulation in type 2 diabetes. We find two chromatin-state signatures that track beta cell dysfunction in mice and humans: ectopic activation of bivalent Polycomb-silenced domains and loss of expression at an epigenomically unique class of lineage-defining genes. beta cell-specific Polycomb (Eed/PRC2) loss of function in mice triggers diabetes-mimicking transcriptional signatures and highly penetrant, hyperglycemia-independent dedifferentiation, indicating that PRC2 dysregulation contributes to disease. The work provides novel resources for exploring beta cell transcriptional regulation and identifies PRC2 as necessary for long-term maintenance of beta cell identity. Importantly, the data suggest a two-hit (chromatin and hyperglycemia) model for loss of beta cell identity in diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据